Cargando…

Respiratory gas kinetics in patients with congestive heart failure during recovery from peak exercise

BACKGROUND: Cardiopulmonary Exercise Testing (CPX) is essential for the assessment of exercise capacity for patients with Chronic Heart Failure (CHF). Respiratory gas and hemodynamic parameters such as Ventilatory Efficiency (VE/VCO(2) slope), peak oxygen uptake (peak VO(2)), and heart rate recovery...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Alessandro, Blumberg, Yair, Hedman, Kristofer, Neunhäuserer, Daniel, Haddad, Francois, Wheeler, Matthew, Ashley, Euan, Moneghetti, Kegan J., Myers, Jonathan, Christle, Jeffrey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310477/
https://www.ncbi.nlm.nih.gov/pubmed/37356413
http://dx.doi.org/10.1016/j.clinsp.2023.100225
Descripción
Sumario:BACKGROUND: Cardiopulmonary Exercise Testing (CPX) is essential for the assessment of exercise capacity for patients with Chronic Heart Failure (CHF). Respiratory gas and hemodynamic parameters such as Ventilatory Efficiency (VE/VCO(2) slope), peak oxygen uptake (peak VO(2)), and heart rate recovery are established diagnostic and prognostic markers for clinical populations. Previous studies have suggested the clinical value of metrics related to respiratory gas collected during recovery from peak exercise, particularly recovery time to 50% (T1/2) of peak VO(2). The current study explores these metrics in detail during recovery from peak exercise in CHF. METHODS: Patients with CHF who were referred for CPX and healthy individuals without formal diagnoses were assessed for inclusion. All subjects performed CPX on cycle ergometers to volitional exhaustion and were monitored for at least five minutes of recovery. CPX data were analyzed for overshoot of respiratory exchange ratio (RER=VCO(2)/VO(2)), ventilatory equivalent for oxygen (VE/VO(2)), end-tidal partial pressure of oxygen (PETO(2)), and T1/2 of peak VO(2) and VCO(2). RESULTS: Thirty-two patients with CHF and 30 controls were included. Peak VO(2) differed significantly between patients and controls (13.5 ± 3.8 vs. 32.5 ± 9.8 mL/Kg*min(−1), p < 0.001). Mean Left Ventricular Ejection Fraction (LVEF) was 35.9 ± 9.8% for patients with CHF compared to 61.1 ± 8.2% in the control group. The T1/2 of VO(2), VCO(2) and VE was significantly higher in patients (111.3 ± 51.0, 132.0 ± 38.8 and 155.6 ± 45.5s) than in controls (58.08 ± 13.2, 74.3 ± 21.1, 96.7 ± 36.8s; p < 0.001) while the overshoot of PETO(2), VE/VO(2) and RER was significantly lower in patients (7.2 ± 3.3, 41.9 ± 29.1 and 25.0 ± 13.6%) than in controls (10.1 ± 4.6, 62.1 ± 17.7 and 38.7 ± 15.1%; all p < 0.01). Most of the recovery metrics were significantly correlated with peak VO(2) in CHF patients, but not with LVEF. CONCLUSIONS: Patients with CHF have a significantly blunted recovery from peak exercise. This is reflected in delays of VO(2), VCO(2), VE, PETO(2), RER and VE/VO(2), reflecting a greater energy required to return to baseline. Abnormal respiratory gas kinetics in CHF was negatively correlated with peak VO(2) but not baseline LVEF.